-
Bayer Schering Pharma AG et al v. Sandoz, Inc. et al DC
- 1:08-cv-08112
- S.D.N.Y.
- Judge: Paul G. Gardephe +1
- Filed: 09/18/2008
- Closed: 09/30/2012
- Latest Docket Entry: 09/30/2012
- PACER
- Docket updated daily
2
Plaintiffs
3
Defendants
1
Accused
Product
1
Patent-in-Suit
1,474
Days in
Litigation
-
Bayer Schering Pharma AG et al v. Sandoz, Inc. et al DC
- 1:08-cv-08112
- S.D.N.Y.
- Judge: Paul G. Gardephe +1
- Filed: 09/18/2008
- Closed: 09/30/2012
- Latest Docket Entry: 09/30/2012
- PACER
- Docket updated daily
Cause of Action
Infringement
Market Sector
Biotech and Pharma
Referred Judge
Assigned Judge
Outcome Summary
- Patent Information
-
Infringement
Sandoz Inc.
- 1 Detail
Accused Product | Patent # | Claim # | Outcome |
---|---|---|---|
0.02 mg of ethinylestradiol in tablet form for oral contraception in a human female3 mg drospirenone, 0.03 mg ethinylestradiol tablet3 mg of drospirenoneDrospirenoneEthinylestradiolGeneric YAZ | US 5,569,652 A | All Asserted Claims |
No infringement
Entry 105Entry 110 |
Accused Product | Patent # | Claim # | Outcome |
---|---|---|---|
0.02 mg of ethinylestradiol in tablet form for oral contraception in a human female3 mg of drospirenone | US 5,569,652 A | All Asserted Claims |
No infringement
Entry 105
|
Watson Pharmaceuticals, Inc.
- 1 Detail
Accused Product | Patent # | Claim # | Outcome |
---|---|---|---|
0.02 mg of ethinylestradiol in tablet form for oral contraception in a human female3 mg of drospirenoneDrospirenone, Ethinylestradiol, Generic Yaz, Generic YAZ | US 5,569,652 A | All Asserted Claims |
No infringement
Entry 105Entry 110 |